Systemic Anti Cancer Therapy Protocols

These clinical protocols have been developed by local clinicians, with the support of the South West Clinical Network (SWCN). The information is provided as guidance only, and has no legal or official standing. The guidance does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer. Availability of treatments may change, subject to NHS funding agreements. These protocols must be used in conjunction with local and national commissioning guidance.

The protocols are still being updated and more will be added to this website as they are completed. If you have any queries or suggestions, or would like to be involved in the development of these protocols please contact us

Fluorouracil, Epirubicin (75) and Cyclophosphamide (FEC 75)

Early and locally advanced disease

Oncology

Docetaxel, Carboplatin, Trastuzumab and Pertuzumab (TCHP)

Early and locally advanced disease

Oncology

Carboplatin and Paclitaxel

Early and locally advanced disease

Oncology

Docetaxel and Cyclophosphamide

Early and locally advanced disease

Oncology

Docetaxel and Carboplatin

Early and locally advanced disease

Oncology

Search by filter

  • Haematology/Oncology

  • Location

  • Protocol Area